These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37407690)

  • 1. Extensive reduction in choroidal thickness after photodynamic therapy in eyes with central serous chorioretinopathy.
    Nishigori N; Muraoka Y; Ishikura M; Kogo T; Ueda-Arakawa N; Miyata M; Tamura H; Hata M; Takahashi A; Miyake M; Tsujikawa A
    Sci Rep; 2023 Jul; 13(1):10890. PubMed ID: 37407690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widefield Choroidal Thickness of Eyes with Central Serous Chorioretinopathy Examined by Swept-Source OCT.
    Ishikura M; Muraoka Y; Nishigori N; Takahashi A; Miyake M; Ueda-Arakawa N; Miyata M; Ooto S; Tsujikawa A
    Ophthalmol Retina; 2022 Oct; 6(10):949-956. PubMed ID: 35436598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L; Lin B; Hong J; Min HB; Han WL; Zhou TY; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of choroidal vasculature in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography.
    Zeng Q; Yao Y; Tu S; Zhao M
    Sci Rep; 2022 Nov; 12(1):18427. PubMed ID: 36319689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Manabe S; Shiragami C; Hirooka K; Izumibata S; Tsujikawa A; Shiraga F
    Am J Ophthalmol; 2015 Apr; 159(4):644-51. PubMed ID: 25595669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Noh SR; Kang MS; Kim K; Kim ES; Yu SY
    Korean J Ophthalmol; 2019 Dec; 33(6):506-513. PubMed ID: 31833247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular and structural alterations of the choroid evaluated by optical coherence tomography angiography and optical coherence tomography after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Demirel S; Özcan G; Yanık Ö; Batıoğlu F; Özmert E
    Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):905-912. PubMed ID: 30617579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microperimetric changes and fixation stability status after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
    Gulkas S; Sahin O
    Eur J Ophthalmol; 2020 Sep; 30(5):1053-1060. PubMed ID: 31256613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
    Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
    Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of irradiated choroid and its regional vortex veins in central serous chorioretinopathy after photodynamic therapy.
    Matsumoto H; Hoshino J; Nakamura K; Kishi S; Akiyama H
    Sci Rep; 2023 Nov; 13(1):19903. PubMed ID: 37963949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choroidal Anatomic Alterations After Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Multicenter Study.
    Iovino C; Au A; Chhablani J; Parameswarappa DC; Rasheed MA; Cennamo G; Cennamo G; Montorio D; Ho AC; Xu D; Querques G; Borrelli E; Sacconi R; Pichi F; Woodstock E; Sadda SR; Corradetti G; Boon CJF; van Dijk EHC; Loewenstein A; Zur D; Yoshimi S; Freund KB; Peiretti E; Sarraf D
    Am J Ophthalmol; 2020 Sep; 217():104-113. PubMed ID: 32360342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in choroidal blood flow after half and one-third dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
    Kumashiro S; Takagi S; Itokawa T; Tajima A; Kobayashi T; Hori Y
    BMC Ophthalmol; 2021 May; 21(1):241. PubMed ID: 34053440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
    Razavi S; Souied EH; Cavallero E; Weber M; Querques G
    Am J Ophthalmol; 2014 Apr; 157(4):852-60. PubMed ID: 24412124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes of Full-Fluence and Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
    Son BK; Kim K; Kim ES; Yu SY
    Ophthalmologica; 2019; 241(2):105-115. PubMed ID: 30110697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
    Smretschnig E; Ansari-Shahrezaei S; Hagen S; Glittenberg C; Krebs I; Binder S
    Retina; 2013 Feb; 33(2):316-23. PubMed ID: 23314238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy].
    Zeng J; Yan YY; Ding XY; Liu R; Li JQ
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):490-4. PubMed ID: 24119960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
    Demircan A; Yesilkaya C; Alkin Z
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():375-378. PubMed ID: 29409857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.